Draft Current Intelligence Bulletin “Update of NIOSH Carcinogen Classification and Target Risk Level Policy for Chemical Hazards in the Workplace”, 68849-68850 [2013-27375]
Download as PDF
Federal Register / Vol. 78, No. 221 / Friday, November 15, 2013 / Notices
LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013–27402 Filed 11–14–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[CDC–2013–0023; Docket Number NIOSH
240–A]
Draft Current Intelligence Bulletin
‘‘Update of NIOSH Carcinogen
Classification and Target Risk Level
Policy for Chemical Hazards in the
Workplace’’
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of draft document
available for public comment and public
meeting.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the availability of the
following draft document for public
comment entitled ‘‘Current Intelligence
Bulletin: Update of NIOSH Carcinogen
Classification and Target Risk Level
Policy for Chemical Hazards in the
Workplace.’’ To view the notice,
document and related materials, visit
https://www.regulations.gov and enter
CDC–2013–0023 in the search field and
click ‘‘Search.’’ Additional information
is also located at the following Web site:
https://www.cdc.gov/niosh/topics/
cancer/policy.html. Comments may be
provided to the NIOSH docket, as well
as given orally at the following meeting.
Public Comment Period: Comments
must be received by February 13, 2014.
Public Meeting Time and Date:
December 16, 2013, 9 a.m.–4 p.m.,
Eastern Time. Please note that public
comments may end before the time
indicated, following the last call for
comments. Members of the public who
wish to provide public comments
should plan to attend the meeting at the
start time listed.
Place: Surface Transportation Board
Hearing Room, Patriots Plaza One, 395
E Street SW., 1st Floor, Room 120,
Washington, DC 20201.
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:58 Nov 14, 2013
Jkt 232001
Status: The meeting is open to the
public, limited only by the space
available. The meeting space
accommodates approximately 150
people. In addition, there will be an
audio conference for those who cannot
attend in person. There is no
registration fee to attend this public
meeting. However, those wishing to
attend are encouraged to register by
December 3, 2013 with the NIOSH
Docket Office at 513/533–8611 or email
niocindocket@cdc.gov.
Security Considerations: Due to
mandatory security clearance
procedures at the Patriots Plaza
Building, in-person attendees must
present valid government-issued picture
identification to security personnel
upon entering the building and go
through an airport-type security check.
Non-U.S. citizens: Because of CDC
Security Regulations, any non-U.S.
citizen wishing to attend this meeting
must provide the following information
in writing to the NIOSH Docket Officer
at the address below no later than
November 22, 2013 to allow time for
mandatory CDC facility security
clearance procedures to be completed.
1. Name:
2. Gender:
3. Date of Birth:
4. Place of birth (city, province, state,
country):
5. Citizenship:
6. Passport Number:
7. Date of Passport Issue:
8. Date of Passport Expiration:
9. Type of Visa:
10. U.S. Naturalization Number (if a
naturalized citizen):
11. U.S. Naturalization Date (if a
naturalized citizen):
12. Visitor’s Organization:
13. Organization Address:
14. Organization Telephone Number:
15. Visitor’s Position/Title within the
Organization:
This information will be transmitted
to the CDC Security Office for approval.
Visitors will be notified as soon as
approval has been obtained. Non-U.S.
citizens are encouraged to participate in
the audio conferencing due to the extra
clearance involved with in-person
attendance.
Attendee and Speaker Registration:
Attendees are encouraged to sign up by
December 3, 2013 with the NIOSH
Docket Office. Individuals wishing to
speak during the meeting may sign up
when registering with the NIOSH
Docket Office no later than December 3,
at 513/533–8611 or by email at
nioshdocket@cdc.gov. Those who have
not signed up to present in advance may
be allowed to present at the meeting if
time allows.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
68849
Persons wanting to provide oral
comments will be permitted up to 20
minutes. If additional time becomes
available, presenters will be notified.
Oral comments given at the meeting
must also be submitted to the docket in
writing in order to be considered by the
Agency.
Priority for attendance will be given
to those providing oral comments. Other
requests to attend the meeting will then
be accommodated on a first-come basis.
Unreserved walk-in attendees will not
be admitted due to security clearance
requirements.
Purpose of Meeting: To discuss and
obtain comments on the draft document,
‘‘Current Intelligence Bulletin: Update
of NIOSH Carcinogen Classification and
Target Risk Level Policy for Chemical
Hazards in the Workplace.’’ Special
emphasis will be placed on discussion
of the following:
Overall Questions
(1) Are the proposed carcinogen
policies consistent with the current
scientific knowledge of toxicology, risk
assessment, industrial hygiene, and
occupational cancer? If not, provide
specific information and references that
should be considered.
(2) Is there additional scientific
information related to the issues of the
proposed NIOSH carcinogen policies
that should be considered for inclusion?
If so, provide information and specify
references for consideration. Is there any
discussion in the document that should
be omitted?
(3) Is the proposed carcinogen
classification policy explained in a clear
and transparent manner? Is the basis for
the proposed policy adequately
explained? If not, specify (section, page,
and line number) where clarification is
needed.
(4) Are there issues relevant to the
classification of occupational
carcinogens that have not been
adequately addressed in this proposed
policy? If so, provide information and
specify references for consideration.
(5) NIOSH adapted the OSHA Hazard
Communication Table Relating
Approximate Equivalences among
IARC, NTP RoC, and GHS
Carcinogenicity Classifications
(Appendix F, Part D, OSHA Globally
Harmonized System for Hazard
Communication) to provide a simple,
systematic method of determining GHS
cancer hazard categories. However,
NIOSH has further considered the GHS
carcinogen categories 1B and 2 because
NTP classification reasonably
anticipated to be a human carcinogen
and IARC classification 2B have criteria
that overlap the two GHS categories.
E:\FR\FM\15NON1.SGM
15NON1
emcdonald on DSK67QTVN1PROD with NOTICES
68850
Federal Register / Vol. 78, No. 221 / Friday, November 15, 2013 / Notices
NIOSH has reviewed the criteria for
GHS classification and has determined
that chemicals classified by NTP as
reasonably anticipated and chemicals
classified as IARC 2B ‘‘that have
sufficient evidence from animal data’’
meet the criteria for GHS Carcinogen
Category 1B. Chemicals classified by
NTP as reasonably anticipated and
chemicals classified by IARC as 2B ‘‘that
have limited evidence from animal
data’’ meet the criteria for GHS
Carcinogen Category 2. NIOSH is
requesting comments on the validity of
the NIOSH Correspondence table (Table
2) and its usefulness as a guide to
determine GHS hazard categories.
(6) Is the proposed target risk level
policy explained in a clear and
transparent manner? Is the basis for the
proposed policy adequately explained?
If not, specify (section, page, and line
number) where clarification is needed.
(7) An analytical feasibility (AF)
notation will be used to identify those
RELs that are established to reflect the
limitations of the sampling and
analytical method (i.e., AF) and not the
target risk level of 1 in 1,000. Is this
notation adequately explained?
(8) Is the proposed analytical
feasibility and technical achievability
policy explained in a clear and
transparent manner? Is the basis for the
proposed policy adequately explained?
If not, specify (section, page, and line
number) where clarification is needed.
Written comments will be accepted at
the meeting. Written comments may
also be submitted by any of the
following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, 4676 Columbia
Parkway, MS C–34, Cincinnati, Ohio
45226.
All material submitted to the Agency
should reference the agency name and
docket number [CDC–2013–0023;
NIOSH 240–A]. All electronic
comments should be formatted as
Microsoft Word. Please make reference
to CDC–2013–0023 and Docket Number
NIOSH 240–A.
Transcript: A transcript will be
prepared and posted to NIOSH Docket
within 30 days after the meeting. Each
person making a comment will be asked
to give his or her name and affiliation,
and all comments (including their name
and affiliation) are considered to be in
the public domain, and the transcript
will be archived in the NIOSH Docket
and posted on a public Web site.
All information received in response
to this notice will be available for public
examination and copying at the NIOSH
VerDate Mar<15>2010
16:58 Nov 14, 2013
Jkt 232001
Docket Office, Room 111, 4676
Columbia Parkway, Cincinnati, Ohio
45226.
Background: This draft NIOSH
document provides an update of the
NIOSH Carcinogen Classification and
relevant Recommended Exposure Limit
(REL) policies. The proposed update of
policies is prompted by comments from
the public and stakeholders and recent
developments in how the carcinogenic
risk to substances is assessed. NIOSH
stakeholders have recently expressed
concerns about limitations in the
NIOSH approach to classifying and
controlling carcinogens. A major
limitation identified is use of the term
‘‘Potential Occupational Carcinogen’’
which dates to the OSHA hazard
classification for carcinogens outlined
in 29 CFR 1990.103 (see below). The
adjective ‘‘potential’’ conveys
uncertainty that is not warranted with
many carcinogens such as asbestos,
benzene, and others.
Further, the existing NIOSH
carcinogen policy does not allow for
classification on the basis of the
magnitude and sufficiency of the
scientific evidence. In contrast, other
organizations such as the National
Toxicology Program (NTP), the
International Agency for Research on
Cancer (IARC) and the Environmental
Protection Agency (EPA) have
differential classification systems with
categories that reflect the weight of
scientific evidence.
Coincident with NIOSH recognition of
this language limitation was
international recognition of the need for
more efficient and faster classification of
substances and the consideration of
alternative substances that are less toxic
and more environmentally sustainable.
In August 2011, NIOSH published in
the Federal Register its intent to review
and request for information regarding its
approach to classifying carcinogens and
establishing recommended exposure
limits for occupational exposures to
hazards associated with cancer. The
initial comment period of September 22,
2011 was subsequently extended until
December 30, 2011. On December 12,
2011, a public meeting was held at the
Hubert H. Humphrey Building in
Washington, DC to engage stakeholders
and members of the public in
discussions of the relevant issues
pertaining to the NIOSH assessment.
Input received from the public and
stakeholders during this process was
considered and is reflected in the draft
document now available for public
review. To view this docket’s previous
information go to: https://www.cdc.gov/
niosh/docket/archive/docket240.html.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
The purpose of the public review of
the draft document is to obtain
comments on whether NIOSH has
adequately explained the basis for its
revised policies on classifying
chemicals as carcinogens and deriving
RELs that are transparent, consistent,
and that contribute to the effective risk
management of chemical carcinogens in
the workplace.
Contact Persons for Technical
Information: T.J. Lentz, telephone (513)
533–8260, or Faye Rice, telephone (513)
533–8335, NIOSH, MS–C32, Robert A.
Taft Laboratories, 4676 Columbia
Parkway, Cincinnati, Ohio 45226.
Dated: November 8, 2013.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 2013–27375 Filed 11–14–13; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–14–0210]
Proposed Data Collections Submitted
for Public Comment and
Recommendations; List of Ingredients
Added to Tobacco in the Manufacture
of Cigarette Products; Withdrawn
Centers for Disease Control and
Prevention (CDC), Office on Smoking
and Health, National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Department of
Health and Human Services (HHS).
ACTION: Notice Withdrawal. In
compliance with the requirement of
Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 FR Doc. 2013–
26469 Filed 11–4–13; 8:45am.
AGENCY:
The Centers for Disease
Control and Prevention requests
withdrawal from publication the 60-Day
Federal Register Notice (FRN) 14 0210
concerning the List of Ingredients
Added to Tobacco in the Manufacture of
Cigarette Products (FR Doc. 2013–
26469), which was submitted on
October 30, 2013 for public inspection
in the Federal Register.
The purpose behind this notice
withdrawal request is that an original
60-day FRN was previously published
on October 31, 2013 (Document
Number—2013–25799). A duplicate 60day FRN was inadvertently published
on November 5, 2013. Please disregard
the duplicate FRN.
SUMMARY:
E:\FR\FM\15NON1.SGM
15NON1
Agencies
[Federal Register Volume 78, Number 221 (Friday, November 15, 2013)]
[Notices]
[Pages 68849-68850]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-27375]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[CDC-2013-0023; Docket Number NIOSH 240-A]
Draft Current Intelligence Bulletin ``Update of NIOSH Carcinogen
Classification and Target Risk Level Policy for Chemical Hazards in the
Workplace''
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of draft document available for public comment and
public meeting.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC)
announces the availability of the following draft document for public
comment entitled ``Current Intelligence Bulletin: Update of NIOSH
Carcinogen Classification and Target Risk Level Policy for Chemical
Hazards in the Workplace.'' To view the notice, document and related
materials, visit https://www.regulations.gov and enter CDC-2013-0023 in
the search field and click ``Search.'' Additional information is also
located at the following Web site: https://www.cdc.gov/niosh/topics/cancer/policy.html. Comments may be provided to the NIOSH docket, as
well as given orally at the following meeting.
Public Comment Period: Comments must be received by February 13,
2014.
Public Meeting Time and Date: December 16, 2013, 9 a.m.-4 p.m.,
Eastern Time. Please note that public comments may end before the time
indicated, following the last call for comments. Members of the public
who wish to provide public comments should plan to attend the meeting
at the start time listed.
Place: Surface Transportation Board Hearing Room, Patriots Plaza
One, 395 E Street SW., 1st Floor, Room 120, Washington, DC 20201.
Status: The meeting is open to the public, limited only by the
space available. The meeting space accommodates approximately 150
people. In addition, there will be an audio conference for those who
cannot attend in person. There is no registration fee to attend this
public meeting. However, those wishing to attend are encouraged to
register by December 3, 2013 with the NIOSH Docket Office at 513/533-
8611 or email niocindocket@cdc.gov.
Security Considerations: Due to mandatory security clearance
procedures at the Patriots Plaza Building, in-person attendees must
present valid government-issued picture identification to security
personnel upon entering the building and go through an airport-type
security check.
Non-U.S. citizens: Because of CDC Security Regulations, any non-
U.S. citizen wishing to attend this meeting must provide the following
information in writing to the NIOSH Docket Officer at the address below
no later than November 22, 2013 to allow time for mandatory CDC
facility security clearance procedures to be completed.
1. Name:
2. Gender:
3. Date of Birth:
4. Place of birth (city, province, state, country):
5. Citizenship:
6. Passport Number:
7. Date of Passport Issue:
8. Date of Passport Expiration:
9. Type of Visa:
10. U.S. Naturalization Number (if a naturalized citizen):
11. U.S. Naturalization Date (if a naturalized citizen):
12. Visitor's Organization:
13. Organization Address:
14. Organization Telephone Number:
15. Visitor's Position/Title within the Organization:
This information will be transmitted to the CDC Security Office for
approval. Visitors will be notified as soon as approval has been
obtained. Non-U.S. citizens are encouraged to participate in the audio
conferencing due to the extra clearance involved with in-person
attendance.
Attendee and Speaker Registration: Attendees are encouraged to sign
up by December 3, 2013 with the NIOSH Docket Office. Individuals
wishing to speak during the meeting may sign up when registering with
the NIOSH Docket Office no later than December 3, at 513/533-8611 or by
email at nioshdocket@cdc.gov. Those who have not signed up to present
in advance may be allowed to present at the meeting if time allows.
Persons wanting to provide oral comments will be permitted up to 20
minutes. If additional time becomes available, presenters will be
notified. Oral comments given at the meeting must also be submitted to
the docket in writing in order to be considered by the Agency.
Priority for attendance will be given to those providing oral
comments. Other requests to attend the meeting will then be
accommodated on a first-come basis. Unreserved walk-in attendees will
not be admitted due to security clearance requirements.
Purpose of Meeting: To discuss and obtain comments on the draft
document, ``Current Intelligence Bulletin: Update of NIOSH Carcinogen
Classification and Target Risk Level Policy for Chemical Hazards in the
Workplace.'' Special emphasis will be placed on discussion of the
following:
Overall Questions
(1) Are the proposed carcinogen policies consistent with the
current scientific knowledge of toxicology, risk assessment, industrial
hygiene, and occupational cancer? If not, provide specific information
and references that should be considered.
(2) Is there additional scientific information related to the
issues of the proposed NIOSH carcinogen policies that should be
considered for inclusion? If so, provide information and specify
references for consideration. Is there any discussion in the document
that should be omitted?
(3) Is the proposed carcinogen classification policy explained in a
clear and transparent manner? Is the basis for the proposed policy
adequately explained? If not, specify (section, page, and line number)
where clarification is needed.
(4) Are there issues relevant to the classification of occupational
carcinogens that have not been adequately addressed in this proposed
policy? If so, provide information and specify references for
consideration.
(5) NIOSH adapted the OSHA Hazard Communication Table Relating
Approximate Equivalences among IARC, NTP RoC, and GHS Carcinogenicity
Classifications (Appendix F, Part D, OSHA Globally Harmonized System
for Hazard Communication) to provide a simple, systematic method of
determining GHS cancer hazard categories. However, NIOSH has further
considered the GHS carcinogen categories 1B and 2 because NTP
classification reasonably anticipated to be a human carcinogen and IARC
classification 2B have criteria that overlap the two GHS categories.
[[Page 68850]]
NIOSH has reviewed the criteria for GHS classification and has
determined that chemicals classified by NTP as reasonably anticipated
and chemicals classified as IARC 2B ``that have sufficient evidence
from animal data'' meet the criteria for GHS Carcinogen Category 1B.
Chemicals classified by NTP as reasonably anticipated and chemicals
classified by IARC as 2B ``that have limited evidence from animal
data'' meet the criteria for GHS Carcinogen Category 2. NIOSH is
requesting comments on the validity of the NIOSH Correspondence table
(Table 2) and its usefulness as a guide to determine GHS hazard
categories.
(6) Is the proposed target risk level policy explained in a clear
and transparent manner? Is the basis for the proposed policy adequately
explained? If not, specify (section, page, and line number) where
clarification is needed.
(7) An analytical feasibility (AF) notation will be used to
identify those RELs that are established to reflect the limitations of
the sampling and analytical method (i.e., AF) and not the target risk
level of 1 in 1,000. Is this notation adequately explained?
(8) Is the proposed analytical feasibility and technical
achievability policy explained in a clear and transparent manner? Is
the basis for the proposed policy adequately explained? If not, specify
(section, page, and line number) where clarification is needed.
Written comments will be accepted at the meeting. Written comments
may also be submitted by any of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: NIOSH Docket Office, Robert A. Taft Laboratories,
4676 Columbia Parkway, MS C-34, Cincinnati, Ohio 45226.
All material submitted to the Agency should reference the agency
name and docket number [CDC-2013-0023; NIOSH 240-A]. All electronic
comments should be formatted as Microsoft Word. Please make reference
to CDC-2013-0023 and Docket Number NIOSH 240-A.
Transcript: A transcript will be prepared and posted to NIOSH
Docket within 30 days after the meeting. Each person making a comment
will be asked to give his or her name and affiliation, and all comments
(including their name and affiliation) are considered to be in the
public domain, and the transcript will be archived in the NIOSH Docket
and posted on a public Web site.
All information received in response to this notice will be
available for public examination and copying at the NIOSH Docket
Office, Room 111, 4676 Columbia Parkway, Cincinnati, Ohio 45226.
Background: This draft NIOSH document provides an update of the
NIOSH Carcinogen Classification and relevant Recommended Exposure Limit
(REL) policies. The proposed update of policies is prompted by comments
from the public and stakeholders and recent developments in how the
carcinogenic risk to substances is assessed. NIOSH stakeholders have
recently expressed concerns about limitations in the NIOSH approach to
classifying and controlling carcinogens. A major limitation identified
is use of the term ``Potential Occupational Carcinogen'' which dates to
the OSHA hazard classification for carcinogens outlined in 29 CFR
1990.103 (see below). The adjective ``potential'' conveys uncertainty
that is not warranted with many carcinogens such as asbestos, benzene,
and others.
Further, the existing NIOSH carcinogen policy does not allow for
classification on the basis of the magnitude and sufficiency of the
scientific evidence. In contrast, other organizations such as the
National Toxicology Program (NTP), the International Agency for
Research on Cancer (IARC) and the Environmental Protection Agency (EPA)
have differential classification systems with categories that reflect
the weight of scientific evidence.
Coincident with NIOSH recognition of this language limitation was
international recognition of the need for more efficient and faster
classification of substances and the consideration of alternative
substances that are less toxic and more environmentally sustainable.
In August 2011, NIOSH published in the Federal Register its intent
to review and request for information regarding its approach to
classifying carcinogens and establishing recommended exposure limits
for occupational exposures to hazards associated with cancer. The
initial comment period of September 22, 2011 was subsequently extended
until December 30, 2011. On December 12, 2011, a public meeting was
held at the Hubert H. Humphrey Building in Washington, DC to engage
stakeholders and members of the public in discussions of the relevant
issues pertaining to the NIOSH assessment. Input received from the
public and stakeholders during this process was considered and is
reflected in the draft document now available for public review. To
view this docket's previous information go to: https://www.cdc.gov/niosh/docket/archive/docket240.html.
The purpose of the public review of the draft document is to obtain
comments on whether NIOSH has adequately explained the basis for its
revised policies on classifying chemicals as carcinogens and deriving
RELs that are transparent, consistent, and that contribute to the
effective risk management of chemical carcinogens in the workplace.
Contact Persons for Technical Information: T.J. Lentz, telephone
(513) 533-8260, or Faye Rice, telephone (513) 533-8335, NIOSH, MS-C32,
Robert A. Taft Laboratories, 4676 Columbia Parkway, Cincinnati, Ohio
45226.
Dated: November 8, 2013.
John Howard,
Director, National Institute for Occupational Safety and Health.
[FR Doc. 2013-27375 Filed 11-14-13; 8:45 am]
BILLING CODE 4163-19-P